These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 22073899)
21. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response. Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432 [TBL] [Abstract][Full Text] [Related]
22. Predictive parameters of response to desmopressin in primary nocturnal enuresis. Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis. Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803 [TBL] [Abstract][Full Text] [Related]
24. Primary monosymptomatic nocturnal enuresis in children and adolescents. Lottmann HB; Alova I Int J Clin Pract Suppl; 2007 Sep; (155):8-16. PubMed ID: 17727574 [TBL] [Abstract][Full Text] [Related]
26. The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis. Ozden C; Ozdal OL; Aktas BK; Ozelci A; Altinova S; Memis A Int Urol Nephrol; 2008; 40(3):583-6. PubMed ID: 18320340 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis. Vogt M; Lehnert T; Till H; Rolle U BJU Int; 2010 May; 105(10):1456-9. PubMed ID: 19764973 [TBL] [Abstract][Full Text] [Related]
28. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity. Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206 [TBL] [Abstract][Full Text] [Related]
29. The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review. Perrin N; Sayer L; While A Prim Health Care Res Dev; 2015 Jan; 16(1):21-31. PubMed ID: 24252606 [TBL] [Abstract][Full Text] [Related]
30. Re: desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J. L. Dehoorne, A. M. Raes, E. van Laecke, P. Hoebeke and J. G. Vande Walle J Urol 2006; 176: 754-758. Nørgaard JP; Osterberg O; Holdrup L J Urol; 2007 Mar; 177(3):1204; author reply 1204-5. PubMed ID: 17296451 [No Abstract] [Full Text] [Related]
31. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes. Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456 [TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults. Burgu B; Gökce MI; Gücük A; Soygür T Urology; 2009 Oct; 74(4):915-9. PubMed ID: 19643460 [TBL] [Abstract][Full Text] [Related]
34. Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. Goldberg H; Baniel J; Mano R; Gillon G; Kedar D; Yossepowitch O BJU Int; 2014 Nov; 114(5):727-32. PubMed ID: 24314054 [TBL] [Abstract][Full Text] [Related]
35. Primary Nocturnal Enuresis: A Novel Therapeutic Strategy With Higher Efficacy. Jabbour M; Abou Zahr R; Boustany M Urology; 2019 Feb; 124():241-247. PubMed ID: 30261177 [TBL] [Abstract][Full Text] [Related]
36. Effect of traditional Chinese and Western medicine on nocturnal enuresis in children and indicators of treatment success: Randomized controlled trial. Ma Y; Liu X; Shen Y Pediatr Int; 2017 Nov; 59(11):1183-1188. PubMed ID: 28891253 [TBL] [Abstract][Full Text] [Related]
37. The treatment of primary nocturnal enuresis in Malaysia. Kanaheswari Y Med J Malaysia; 2006 Dec; 61(5):608-15. PubMed ID: 17623963 [TBL] [Abstract][Full Text] [Related]
38. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning. De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291 [TBL] [Abstract][Full Text] [Related]
39. Study of the profile of behavioral problems and quality of life indexes in a pediatric cohort of monosymptomatic enuresis. Sousa E Silva GJ; Sammour SNF; Ferraro AA; Koch VHK J Pediatr (Rio J); 2019; 95(2):188-193. PubMed ID: 29428322 [TBL] [Abstract][Full Text] [Related]
40. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues. Van de Walle J; Van Herzeele C; Raes A Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]